• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Gudjon_Iceland

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Forum Replies Created

Viewing 1 post (of 1 total)
  • Author
    Posts
  • September 29, 2016 at 10:06 pm in reply to: Newcomer #2167
    Gudjon_Iceland
    Participant

      Greetings to you as well my dear friends from Turkey and around the world.

    • Author
      Posts
    Viewing 1 post (of 1 total)

    Primary Sidebar

    Advocacy

    • Advocacy Toolkit

    Approved Drugs

    • Nuedexta
    • Radicava/Edaravone
    • Riluzole/Tiglutik
    • Rozebalamin/Methylcobalamin
    • Tofersen/Qalsody

    Drugs in Development

    • AB Science – Masitinib
    • BrainStorm Cell Therapeutics – NurOwn
    • Clene Nanomedicine – CNM-Au8
    • ILB – Tikomed
    • Kadimastem – AstroRx
    • Methylcobalamin
    • Mitsubishi Tanabe Pharma America – Oral Edaravone
    • Neuronata-R/Lenzumestrocel
    • NeuroSense – PrimeC
    • Neuvivo – NP001
    • Prilenia Therapeutics – Pridopidine
    • SOD1 Therapies & Trials
    • SPG302
    • T Regulatory Cell Therapies
    • Ulefnersen – Ionis Pharmaceuticals

    Care services

    • Genetic Counselling & Testing
    • Mental Health Support
    • Nursing and Symptom Management
    • Nutrition and Swallowing
    • Occupational Therapy and Activities of Daily Living
    • Physiotherapy and Mobility
    • Respiratory Care
    • Speech Therapy and Communication
    • Support for Family & Caregivers
    • Technology

    Support for members

    • Alliance Support Grant
    • About the meetings

    Events/Programs

    • Calendar of Events/Programs
    • Alliance Webinars
    • Alliance Meeting
    • Allied Professionals Forum
    • ALS/MND Connect
    • Global Day Calendar
    • March of Faces
    • International Symposium

    About

    • Who We Are
    • Board of Trustees
    • Councils, Forums & Committees
      • PALS and CALS Advisory Council
      • Scientific Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
      • Newsletters
      • Meetings
    • Awards

    Upcoming Events

    Jul 14
    7:00 am - 8:30 am EDT

    Member Roundtable: From Principles to Practice – Building the Baseline Model for ALS/MND Clinics

    Jul 23
    1:00 pm - 2:00 pm EDT

    Traveling with ALS: What to Know Before You Go

    Aug 19
    8:00 am - 9:00 am EDT

    Member Forum: Equitable Access to Care

    Aug 19
    6:00 pm - 7:00 pm EDT

    Member Forum: Equitable Access to Care

    Sep 8
    8:00 am - 9:00 am EDT

    Member Forum: Health Literacy

    View Calendar

    • Brigitte Wernli, Switzerland

      Brigitte Wernli, Switzerland

    • Roxana Canova, Argentina

      Roxana Canova, Argentina

    • Steve Lufkin, USA

      Steve Lufkin, USA
      IMG_3993

    • Chen Yin Xue, Taiwan

      Chen Yin Xue, Taiwan

    • Wilfried Leusing, Germany

      Wilfried Leusing, Germany

    • Aida Trzmiel de Guterman, Argentina

      Aida Trzmiel de Guterman, Argentina

    • Bob Spurrier, USA

      Bob Spurrier, USA

    • Dorette Lüdi, Switzerland

      Dorette Lüdi, Switzerland

    • Chen Chun-Chin, Malaysia

      Chen Chun-Chin, Malaysia

    • Motoko Ogasawara, Japan

      Motoko Ogasawara, Japan

    • Anderson Custodio Pinto, Brazil

      Anderson Custodio Pinto, Brazil

    • Mauril Belanger, Canada

      Mauril Belanger, Canada

    • Ada Garrido Benavidez, Mexico

      Ada Garrido Benavidez, Mexico

    • Len Johnrose, England

      Len Johnrose, England

    • Emilienne Verhaegen, Belgium

      Emilienne Verhaegen, Belgium

    • Ana María Zavala, Mexico

      Ana María Zavala, Mexico

    • Purningam Jacob, India

      Purningam Jacob, India

    • Francisco Perez Palop, Spain

      Francisco Perez Palop, Spain

    • Xian-Zhang Niu, China

      Xian-Zhang Niu, China

    • Orly Dichoso, Canada

      Orly Dichoso, Canada

    • Josée Kolijn-de Man, Netherlands

      Josée Kolijn-de Man, Netherlands

    • Patrick Shuma, Kenya

      Patrick Shuma, Kenya

    • Willi Klein, UK

      Willi Klein, UK

    • Bjarne Hytjanstorp, Norway

      Bjarne Hytjanstorp, Norway

    • JP

      JP

    • Brian Lovell, Australia

      Brian Lovell, Australia

    • Mirca Bersani, Italy

      Mirca Bersani, Italy
      MircaBersani

    • Catherine Pearce, Australia

      Catherine Pearce, Australia

    • Feng Gin Sun, China

      Feng Gin Sun, China

    • Danny Reviers, Belgium

      Danny Reviers, Belgium

    • Mary Thomas, Australia

      Mary Thomas, Australia

    • Valdomiro Xavier Honório, Brazil

      Valdomiro Xavier Honório, Brazil

    • Fabio Carvalho, Brazil

      Fabio Carvalho, Brazil

    • Yessenia Hernandez Mendoza, Mexico

      Yessenia Hernandez Mendoza, Mexico

    • Fabio Carvalho, Brazil

      Fabio Carvalho, Brazil

    • Cassio Fernando da Silva, Brazil

      Cassio Fernando da Silva, Brazil

    • Graham Johnson, Australia

      Graham Johnson, Australia

    • Oliver Juenke, Germany

      Oliver Juenke, Germany

    • Guido De Mets, Belgium

      Guido De Mets, Belgium

    • Jack Buzby, USA

      Jack Buzby, USA

    • Sanjay Kumar Srivastava, India

      Sanjay Kumar Srivastava, India

    • John Dinon, Australia

      John Dinon, Australia

    • Hans Dieter Olszewski, Germany

      Hans Dieter Olszewski, Germany

    • Jo Knowlton, Scotland

      Jo Knowlton, Scotland

    • Timmy, Belgium

      Timmy, Belgium

    • Ali Var, Turkey

      Ali Var, Turkey

    • Chris McCauley, Canada

      Chris McCauley, Canada

    • Michel Perrozzo, France

      Michel Perrozzo, France

    • Colm Francis Davis, Ireland

      Colm Francis Davis, Ireland

    • Jon Newsome, USA

      Jon Newsome, USA

    Learn more about the March of Faces

    Coronavirus (COVID-19) Resources

    Instructions

    First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

    If you have already registered, please use the details provided to log in using this form.

    Drugs No Longer in Development

    • Amylyx – AMX0035
    • Collaborative Medicinal Development – CuATSM
    • Cytokinetics – Reldesemtiv
    • Orphazyme – Arimoclomol
    • TUDCA Trial

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login